← Evidence map

ArticlePharmaceuticals (Basel, Switzerland)2019

Omadacycline: A Newly Approved Antibacterial from the Class of Tetracyclines.

Fernando Durães et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31010063